Arkolith/Insider Trading/RXRX/Form 4

Taylor Ben R

Chief Financial OfficerRECURSION PHARMACEUTICALS, INC. (RXRX) · full profile →Form 4 · filed Nov 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Tax withholding(F)12K$4.14$49K792K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001712276-25-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML